Johannes A M Merilahti (Johannes Merilahti, Johannes A Merilahti)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Liquid Chromatography

Tyrosine Kinase

Top Venues

The Journal of biological chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Jenni Soukka, Lauri Polari, Otto Kauko, Johannes A M Merilahti, Anne Rokka, Diana M Toivola, Kirsi Laitinen
Improved breast milk proteome coverage by DIA based LC-MS/MS method. Proteomics (2024)
Jenni Soukka, Lauri Polari, Otto Kauko, Johannes A M Merilahti, Anne Rokka, Diana M Toivola, Kirsi Laitinen
Improved breast milk proteome coverage by DIA based LC-MS/MS method. Proteomics 24 (14) (2024)
Katri Vaparanta, Anne Jokilammi, Ilkka Paatero, Johannes A M Merilahti, Juho Heliste, Karthik Amudhala Hemanthakumar, Riikka Kivelä, Kari Alitalo, Pekka Taimen, Klaus Elenius
STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth. EMBO reports (2023)
Katri Vaparanta, Anne Jokilammi, Mahlet Tamirat, Johannes A M Merilahti, Kari Salokas, Markku Varjosalo, Johanna Ivaska, Mark S Johnson, Klaus Elenius
An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation. Nature communications 13 (1) (2022)
Veera K Ojala, Anna M Knittle, Peppi Kirjalainen, Johannes A M Merilahti, Maarit Kortesoja, Denis Tvorogov, Katri Vaparanta, Shujun Lin, Jürgen Kast, Arto T Pulliainen, Kari J Kurppa, Klaus Elenius
The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration. The Journal of biological chemistry 295 (33) (2020)
Johannes A M Merilahti, Klaus Elenius
Gamma-secretase-dependent signaling of receptor tyrosine kinases. Oncogene 38 (2) (2018)